1.06187
N-Méthyle-D-glucamine
EMPROVE® EXPERT, Ph. Eur., ChP, JP, USP
Synonyme(s) :
1-Désoxy-1-(méthylamino)-D-glucitol, Méglumine
Sélectionner une taille de conditionnement
A propos de cet article
Quality Level
agency
ChP, JP, Ph. Eur., USP
product line
EMPROVE® EXPERT
form
solid
autoignition temp.
~662 °F
pH
11 (20 °C, 10 g/L in H2O)
bp
210 °C/1013 hPa
mp
129-131.5 °C (lit.)
application(s)
liquid formulation
pharmaceutical
solid formulation
solubility enhancement
storage temp.
no temp limit
SMILES string
CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
InChI
1S/C7H17NO5/c1-8-2-4(10)6(12)7(13)5(11)3-9/h4-13H,2-3H2,1H3/t4-,5+,6+,7+/m0/s1
InChI key
MBBZMMPHUWSWHV-BDVNFPICSA-N
General description
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
Application
Features and Benefits
- Solubility and bioavailability enhancement of APIs
- Excellent counterion performance, a viable alternative to sodium
- API grade: manufactured under the cGMP ICH Q7 guideline for APIs
- Sole manufacturing location for API-grade meglumine in Europe
- Multi-compendial product, complying with all major pharmacopeias, including ChP
- Meglumine Emprove® API has also been successfully co-reviewed in China
Legal Information
Still not finding the right product?
Explore all of our products under N-Méthyle-D-glucamine
Classe de stockage
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificats d'analyse (COA)
Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Articles
This overview describes the challenges when developing parenteral formulations and strategies to overcome them and reduce the risk of production.
Discover strategies to enhance solubility in injectable formulations using excipients, including cyclodextrins, meglumine, and polyethylene glycols.
Our overview of API solubility and dissolution enhancement methods can help you decide between the many options to take during formulation.
Contenu apparenté
Numéro d'article de commerce international
| Référence | GTIN |
|---|---|
| 1061871000 | 04054839525469 |